Types of arthritis
Rheumatoid Arthritis (RA)
Autoimmune systemic disease. The immune system attacks the synovial membrane of joints. Symmetrical involvement of small joints of hands and feet (metacarpophalangeal, proximal interphalangeal). Morning stiffness over 1 hour. Without treatment — pannus destroys cartilage and bone (erosions). Prevalence: 0.5-1% of population, women 3 times more often.
Osteoarthritis (osteoarthritis with inflammation)
Primary cartilage degeneration with secondary inflammation (synovitis). The most common form of "arthritis." Large joints: knee, Hip Joint, spine. Pain on loading, morning stiffness less than 30 minutes, crepitus. On X-ray: joint space narrowing, osteophytes.
→ Knee Osteoarthritis (Gonarthrosis) | → Hip Osteoarthritis (Coxarthrosis)
Gouty arthritis
Deposition of uric acid crystals. Acute attack: red, hot, sharply painful joint (most often 1st toe). Between attacks — asymptomatic. Diagnosis: blood uric acid, polarized microscopy of aspirate.
Psoriatic arthritis
In 30% of psoriasis patients. Asymmetrical involvement, dactylitis ("sausage digit"), distal interphalangeal joint involvement, enthesitis (tendon attachment inflammation), spondylitis. Nail changes.
Reactive arthritis
Aseptic joint inflammation after infection (genitourinary — chlamydia, gastrointestinal — salmonella, yersinia). Asymmetrical oligoarthritis of lower extremities. Reiter's triad: arthritis + urethritis + conjunctivitis. More common in men 20-40 years old.
Septic (infectious) arthritis
Direct bacterial invasion into the joint. Staphylococcus aureus — 60%. Emergency condition: without treatment — joint destruction in days. Aspiration + culture + antibiotics. MIBRAR® — after infection control for restoration of damaged cartilage.
Arthritis vs osteoarthritis — key differences
Arthritis
Inflammatory process. Morning stiffness > 30-60 min. Swelling, redness, warmth. Can affect any age. Elevated ESR, CRP. On ultrasound — synovitis with Doppler activity.
Osteoarthritis
Degenerative process. Stiffness < 15-30 min. Pain on loading, decreases at rest. More common after 50 years. Laboratory parameters normal. On X-ray — osteophytes, joint space narrowing.
Mixed forms
In practice, often combined: inflammatory osteoarthritis, RA with secondary osteoarthritis. MIBRAR® effective for both components: reduces inflammation and regenerates cartilage.
Role of MIBRAR® in arthritis
Important: MIBRAR® does not replace systemic arthritis therapy (DMARDs for RA, urate-lowering therapy for gout). MIBRAR® restores joints damaged by the inflammatory process.
Cartilage regeneration
Stem cells from Lipogems® differentiate into chondrocytes, restoring the cartilage surface destroyed by inflammatory pannus or crystals.
Immunomodulation
Mesenchymal stem cells have a powerful immunomodulatory effect: they secrete IL-10, TGF-beta, PGE2, suppressing autoimmune inflammation in the joint. This is not immunosuppression, but modulation — normalization of the immune response.
Restoration of Synovial Membrane
CGF normalizes the structure of the synovial membrane, reduces hyperplasia, and restores normal production of synovial fluid.
Inflammation Destroys — MIBRAR® Restores
Don't wait for irreversible erosions. Send images for evaluation.
Send ImagesQuestions about Arthritis
Arthritis is inflammation (immune, infectious, crystalline). Osteoarthritis is degeneration (wear and tear). In arthritis: swelling, redness, stiffness > 30 min. In osteoarthritis: pain on loading, crepitus, stiffness < 15 min.
MIBRAR® restores joints damaged by RA. However, it does not replace systemic therapy. Optimal: MIBRAR® + rheumatologic treatment (methotrexate, biological agents).
ESR, CRP (inflammation), rheumatoid factor, anti-CCP (RA), uric acid (gout), ANA (lupus). Joint ultrasound with Doppler. MRI if erosions are suspected.
Yes, with early treatment initiation. Modern rheumatology + MIBRAR® for regeneration. Key — early detection and aggressive treatment.

